These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 10818726)

  • 1. Assays for antibody-dependent cell-mediated cytotoxicity (ADCC) and reverse ADCC (redirected cytotoxicity) in human natural killer cells.
    Perussia B; Loza MJ
    Methods Mol Biol; 2000; 121():179-92. PubMed ID: 10818726
    [No Abstract]   [Full Text] [Related]  

  • 2. CD8-interaction mutant HLA-Cw3 molecules protect porcine cells from human natural killer cell-mediated antibody-dependent cellular cytotoxicity without stimulating cytotoxic T lymphocytes.
    Sharland A; Lee JH; Saidman S; Waneck GL
    Transplantation; 2003 Dec; 76(11):1615-22. PubMed ID: 14702534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced natural killer cell binding and activation by low-fucose IgG1 antibody results in potent antibody-dependent cellular cytotoxicity induction at lower antigen density.
    Niwa R; Sakurada M; Kobayashi Y; Uehara A; Matsushima K; Ueda R; Nakamura K; Shitara K
    Clin Cancer Res; 2005 Mar; 11(6):2327-36. PubMed ID: 15788684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The anti-lymphoma effect of antibody-mediated immunotherapy is based on an increased degranulation of peripheral blood natural killer (NK) cells.
    Fischer L; Penack O; Gentilini C; Nogai A; Muessig A; Thiel E; Uharek L
    Exp Hematol; 2006 Jun; 34(6):753-9. PubMed ID: 16728280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. lenalidomide enhances natural killer cell and monocyte-mediated antibody-dependent cellular cytotoxicity of rituximab-treated CD20+ tumor cells.
    Wu L; Adams M; Carter T; Chen R; Muller G; Stirling D; Schafer P; Bartlett JB
    Clin Cancer Res; 2008 Jul; 14(14):4650-7. PubMed ID: 18628480
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antibody-dependent cytotoxic method of determining the number of natural killer cells in the peripheral blood].
    Pastushenkov VL; Mitin IuA; Kuz'mich AN
    Lab Delo; 1991; (7):48-9. PubMed ID: 1724038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of homology between human and chicken K cells.
    Nowak J
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):407-11. PubMed ID: 7294975
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NK cells stimulated with IL-15 or CpG ODN enhance rituximab-dependent cellular cytotoxicity against B-cell lymphoma.
    Moga E; Alvarez E; Cantó E; Vidal S; Rodríguez-Sánchez JL; Sierra J; Briones J
    Exp Hematol; 2008 Jan; 36(1):69-77. PubMed ID: 17959301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Standardisation of a homologous antibody-dependent cell mediated cytotoxicity (ADCC) assay for bioclinical use.
    Greiss MA
    Med Lab Sci; 1988 Jan; 45(1):74-82. PubMed ID: 3143884
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibody-dependent cell-mediated cytotoxicity (ADCC)].
    Mukaida N
    Nihon Rinsho; 2010 Jun; 68 Suppl 6():33-5. PubMed ID: 20941995
    [No Abstract]   [Full Text] [Related]  

  • 11. A novel EGFP-CEM-NKr flow cytometric method for measuring antibody dependent cell mediated-cytotoxicity (ADCC) activity in HIV-1 infected individuals.
    Kantakamalakul W; Pattanapanyasat K; Jongrakthaitae S; Assawadarachai V; Ampol S; Sutthent R
    J Immunol Methods; 2006 Aug; 315(1-2):1-10. PubMed ID: 16884734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methods for measuring antibody-dependent cell-mediated cytotoxicity in vitro.
    Miller AS; Tejada ML; Gazzano-Santoro H
    Methods Mol Biol; 2014; 1134():59-65. PubMed ID: 24497354
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Defucosylated anti-CCR4 monoclonal antibody exercises potent ADCC-mediated antitumor effect in the novel tumor-bearing humanized NOD/Shi-scid, IL-2Rgamma(null) mouse model.
    Ito A; Ishida T; Yano H; Inagaki A; Suzuki S; Sato F; Takino H; Mori F; Ri M; Kusumoto S; Komatsu H; Iida S; Inagaki H; Ueda R
    Cancer Immunol Immunother; 2009 Aug; 58(8):1195-206. PubMed ID: 19048251
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulation of natural killer cell activity, antibody-dependent cellular cytotoxicity, and antibody-dependent complement-mediated cytotoxicity by andrographolide in normal and Ehrlich ascites carcinoma-bearing mice.
    Sheeja K; Kuttan G
    Integr Cancer Ther; 2007 Mar; 6(1):66-73. PubMed ID: 17351028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibody-dependent cell-mediated cytotoxicity (ADCC) in gastric and colorectal cancer].
    Sekizuka H; Noro K; Haruyama S; Kiribuchi Y; Hayashi F
    Gan No Rinsho; 1986 Jul; 32(8):879-82. PubMed ID: 3747148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natural killing (NK) and antibody-dependent cellular cytotoxicity (ADCC) in specific pathogen-free (SPF) miniature swine and germfree piglets. I. Comparison of NK and ADCC.
    Kim YB; Huh ND; Koren HS; Amos DB
    J Immunol; 1980 Aug; 125(2):755-62. PubMed ID: 6446578
    [No Abstract]   [Full Text] [Related]  

  • 17. Chimeric and humanized anti-HM1.24 antibodies mediate antibody-dependent cellular cytotoxicity against lung cancer cells.
    Wang W; Nishioka Y; Ozaki S; Jalili A; Verma VK; Hanibuchi M; Abe S; Minakuchi K; Matsumoto T; Sone S
    Lung Cancer; 2009 Jan; 63(1):23-31. PubMed ID: 18524412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophils contribute to the biological antitumor activity of rituximab in a non-Hodgkin's lymphoma severe combined immunodeficiency mouse model.
    Hernandez-Ilizaliturri FJ; Jupudy V; Ostberg J; Oflazoglu E; Huberman A; Repasky E; Czuczman MS
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5866-73. PubMed ID: 14676108
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhancement of the antibody-dependent cellular cytotoxicity of low-fucose IgG1 Is independent of FcgammaRIIIa functional polymorphism.
    Niwa R; Hatanaka S; Shoji-Hosaka E; Sakurada M; Kobayashi Y; Uehara A; Yokoi H; Nakamura K; Shitara K
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6248-55. PubMed ID: 15448014
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant interleukin-2 significantly augments activity of rituximab in human tumor xenograft models of B-cell non-Hodgkin lymphoma.
    Lopes de Menezes DE; Denis-Mize K; Tang Y; Ye H; Kunich JC; Garrett EN; Peng J; Cousens LS; Gelb AB; Heise C; Wilson SE; Jallal B; Aukerman SL
    J Immunother; 2007 Jan; 30(1):64-74. PubMed ID: 17198084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.